RSV can be significantly worse than a common cold, though in many healthy adults the two infections feel almost identical. The real difference shows up in who gets sick: RSV is the leading cause of infant hospitalization in the United States, and it kills an estimated 6,000 to 10,000 adults over 65 each year. A regular cold almost never does either of those things.
Both infections start the same way, with a runny nose, sore throat, and mild fever. What separates RSV is its ability to move deeper into the lungs, where it can cause serious breathing problems that a cold virus rarely triggers.
Why RSV Hits Harder Than a Cold
The common cold is usually caused by rhinoviruses, which were long thought to stay in the upper airways (nose and throat) where temperatures are cooler. We now know rhinoviruses can reach the lower airways too, but they typically cause mild illness when they do. RSV, by contrast, has a particular tendency to infect the small airways deep in the lungs called bronchioles. Once there, it damages the lining of those tiny tubes, causing swelling, mucus buildup, and narrowing of the air passages.
This is the condition known as bronchiolitis, and it’s the main reason RSV sends so many infants to the hospital. In babies, those bronchioles are already tiny. When they swell shut, a baby has to work visibly harder to breathe. A cold rarely progresses this way.
How the Symptoms Compare
In the first few days, RSV and a cold look nearly identical. Both cause a runny nose, sneezing, headache, mild cough, and sometimes a low-grade fever. Most healthy adults with RSV will never know it wasn’t just a cold. The differences emerge when the infection moves into the lower respiratory tract.
Three signs point toward RSV rather than a standard cold:
- Wheezing. A whistling sound when breathing is common with RSV but unusual with a mild cold.
- Worsening symptoms. Colds tend to peak around day three or four and then improve. RSV symptoms can get worse over time instead of better.
- Breathing difficulty. A worsening cough, visible effort to breathe, or skin that looks blue or gray signals that the infection has moved beyond typical cold territory.
In infants under six months, RSV can look deceptively subtle. The main signs may not be respiratory at all: unusual irritability, reduced activity, poor appetite, or brief pauses in breathing.
Who Faces the Greatest Risk
For healthy older children and adults, RSV is usually no worse than a bad cold. The people at serious risk fall into three groups.
Infants. RSV is the leading cause of hospitalization for babies in the U.S. Their airways are small enough that even moderate swelling can make breathing difficult. Warning signs include rapid, shallow breathing, chest muscles pulling inward with each breath, flaring nostrils, head bobbing, and grunting sounds.
Adults over 65. RSV causes an estimated 60,000 to 160,000 hospitalizations each year among older adults. A CDC study comparing hospitalized patients over 60 found that 13.5% of those with RSV needed mechanical ventilation or died, compared to 7% of those hospitalized with the flu. RSV was roughly twice as dangerous as influenza in this age group, and comparable to COVID-19 in severity.
People with weakened immune systems. Anyone with a compromised immune system or chronic lung or heart disease faces higher odds of RSV progressing to pneumonia or bronchiolitis.
Recovery Timeline
Both RSV and a typical cold last about one to two weeks. Symptoms of RSV generally peak within the first week, and most people recover fully within 14 days. That’s similar to the standard 7-to-10-day cold window, though RSV’s cough and congestion sometimes linger a bit longer.
The difference isn’t so much in duration as in the chance of complications during that window. A cold almost never requires medical intervention. RSV occasionally does, particularly if breathing becomes labored or oxygen levels drop.
Testing and Diagnosis
Most people with RSV will never be tested for it. If you’re a healthy adult with cold-like symptoms, your doctor will likely treat it the same way they’d treat any cold: rest and fluids. There’s no routine reason to distinguish between the two.
Testing becomes relevant for infants, adults over 65, and immunocompromised individuals when symptoms are moderate to severe. The triggers for testing include fever, wheezing, a serious cough, breathing faster than normal, or bluish skin. The test itself is straightforward, usually a nasal swab.
Prevention Options
There’s no vaccine or immunization for the common cold, largely because it’s caused by more than 200 different viruses. RSV, being a single virus, is a more targetable problem.
An immunization called nirsevimab is now available for infants entering their first RSV season. In real-world data, it was 90% effective at preventing RSV-related hospitalization. In clinical trials, a single dose given before 8 months of age was 79% effective against RSV infections requiring a doctor visit and 81% effective against those requiring hospitalization, with protection lasting about five months. Vaccines for older adults have also become available in recent years.
No equivalent protection exists for the common cold, but the common cold also rarely warrants it.